Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
US-10040770-B2 · Aug 7, 2018 · US
US10919865B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10919865-B2 |
| Application number | US-201916291193-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 4, 2019 |
| Priority date | Apr 22, 2011 |
| Publication date | Feb 16, 2021 |
| Grant date | Feb 16, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided herein are Diaminopyrimidine Compounds having the following structures: wherein R 1 , R 2 , R 3 , and R 4 are as defined herein, compositions comprising an effective amount of a Diaminopyrimidine Compound, and methods for treating or preventing liver fibrotic disorders or a condition treatable or preventable by inhibition of a JNK pathway.
Opening claim text (preview).
What is claimed is: 1. A method for preparing a compound of formula (I): the method comprising contacting a compound of formula (Ia) with R 1 NH 2 in a solvent, in the presence of an organic base, wherein: R 1 is substituted or unsubstituted C 1-8 alkyl, substituted or unsubstituted saturated or partially saturated cycloalkyl, substituted or unsubstituted non-aromatic heterocyclyl, substituted or unsubstituted alkyl-(saturated or partially saturated cycloalkyl), or substituted or unsubstituted alkylheterocyclyl, provided that R 1 is not 2 aminocyclohexyl; R 2 is substituted or unsubstituted C 1-8 alkyl, substituted or unsubstituted saturated C 5-10 cycloalkyl, substituted or unsubstituted alkyl-(saturated or partially saturated cycloalkyl, substituted or unsubstituted non-aromatic heterocyclyl; R x is a C 1-2 alkyl; and m is 1 or 2, wherein when a C 1-8 alky group is substituted, the C 1-8 alkyl group is substituted with halogen, alkyl, hydroxyl, alkoxy, alkoxyalkyl, amino, alkylamino, carboxy, nitro, cyano, thiol, thioether, imine, imide, amidine, guanidine, enamine, aminocarbonyl, acylamino, phosphonato, phosphine, thiocarbonyl, sulfonyl, sulfone, sulfonamide, ketone, aldehyde, ester, urea, urethane, oxime, hydroxyl amine, alkoxyamine, aralkoxyamine, N-oxide, hydrazine, hydrazide, hydrazone, azide, isocyanate, isothiocyanate, cyanate, thiocyanate, B(OH) 2 , or O(alkyl)aminocarbonyl; wherein when a group, other than a C 1-8 alkyl group, is substituted, the group is substituted with halogen, alkyl, hydroxyl, alkoxy, alkoxyalkyl, amino, alkylamino, carboxy, nitro, cyano, thiol, thioether, imine, imide, amidine, guanidine, enamine, aminocarbonyl, acylamino, phosphonato, phosphine, thiocarbonyl, sulfonyl, sulfone, sulfonamide, ketone, aldehyde, ester, urea, urethane, oxime, hydroxyl amine, alkoxyamine, aralkoxyamine, N-oxide, hydrazine, hydrazide, hydrazone, azide, isocyanate, isothiocyanate, cyanate, thiocyanate, oxo, B(OH) 2 , O(alkyl)aminocarbonyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, aryloxy, aralkyloxy, heterocyclyloxy or heterocyclylalkoxy. 2. The method of claim 1 , further comprising preparing a compound of formula (Ia): the method comprising oxidizing a compound of formula (Ib) in a solvent by treatment with an oxidant selected from mCPBA, oxone, hydrogen peroxide, or 3-phenyl-2-(phenylsulfonyl)-1,2-oxaziridine. 3. The method of claim 2 , further comprising preparing a compound of formula (Ib): the method comprising contacting a compound of formula (Ic) with NH 4 Cl, in the presence of a coupling agent and a base, in a solvent. 4. The method of claim 3 , further comprising preparing a compound of formula (Ic) the method comprising contacting a compound of formula (Id) with an aqueous base, in a cosolvent. 5. The method of claim 4 , further comprising preparing a compound of formula (Id) the method comprising contacting a compound of formula (Ie) with R 2 NH 2 in an organic solvent, in the presence of a base. 6. A method for preparing a compound of formula (I): the method comprising (1) contacting a compound of formula (If) with peroxide, in the presence of a base, in a solvent to give a compound of formula (Ib) (2) oxidizing the compound of formula (Ib) in a solvent by treatment with an oxidant selected from mCPBA, oxone, hydrogen peroxide, or 3-phenyl-2-(phenylsulfonyl)-1,2-oxaziridine to give a compound of formula (Ia): (3) contacting the compound of formula (Ia) with R 1 NH 2 in a solvent, in the presence of an organic base, wherein: R 1 is substituted or unsubstituted C 1-8 alkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted non-aromatic heterocyclyl, substituted or unsubstituted alkylcycloalkyl, or substituted or unsubstituted alkylheterocyclyl, provided that R 1 is not 2-aminocyclohexyl; R 2 is substituted or unsubstituted C 1-8 alkyl, substituted or unsubstituted saturated cycloalkyl, substituted or unsubstituted alkylcycloalkyl, substituted or unsubstituted non-aromatic heterocyclyl; R x is a C 1-2 alkyl; and m is 1 or 2. 7. The method of claim 6 , further comprising preparing a compound of formula (If) the method comprising contacting a compound of formula (Ig) with R 2 NH 2 in an organic solvent, in the presence of a base. 8. The method of claim 1 , wherein the compound of Formula (I) is 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide. 9. A method for preparing a compound of formula (I): the method comprising contacting a compound of formula (IIa) with R 2 NH 2 in a solvent, in the presence of an organic base, wherein: R 1 is substituted or unsubstituted C 1-8 alkyl, substituted or unsubstituted saturated or partially saturated cycloalkyl, substituted or unsubstituted non-aromatic heterocyclyl, substituted or unsubstituted alkyl-(saturated or partially saturated cycloalkyl), or substituted or unsubstituted alkylheterocyclyl, provided that R 1 is not 2 aminocyclohexyl; R 2 is substituted or unsubstituted C 1-8 alkyl, substituted or unsubstituted saturated C 5-10 cycloalkyl, substituted or unsubstituted alkyl-(saturated or partially saturated cycloalkyl, substituted or unsubstituted non-aromatic heterocyclyl; R x is a C1-2 alkyl; and m is 1 or 2, wherein when a C 1-8 alky group is substituted, the C 1-8 alkyl group is substituted with halogen, alkyl, hydroxyl, alkoxy, alkoxyalkyl, amino, alkylamino, carboxy, nitro, cyano, thiol, thioether, imine, imide, amidine, guanidine, enamine, aminocarbonyl, acylamino, phosphonato, phosphine, thiocarbonyl, sulfonyl, sulfone, sulfon
for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants · CPC title
One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine · CPC title
One sulfur atom · CPC title
Two nitrogen atoms · CPC title
Antineoplastic agents · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.